Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Benign prostatic hyperplasia.

× No keyword cloud information.

54 in total

1. Natural history of prostatism: risk factors for acute urinary retention.

Authors: S J Jacobsen; D J Jacobson; C J Girman; R O Roberts; T Rhodes; H A Guess; M M Lieber
Journal: J Urol Date: 1997-08 Impact factor: 7.450

2. Natural history of benign prostatic hyperplasia: appropriate case definition and estimation of its prevalence in the community.

Authors: J L Bosch; W C Hop; W J Kirkels; F H Schröder
Journal: Urology Date: 1995-09 Impact factor: 2.649

3. Effects of doxazosin in patients with mild, intermediate, and severe benign prostatic hyperplasia.

Authors: D F Mobley; N Dias; M Levenstein
Journal: Clin Ther Date: 1998 Jan-Feb Impact factor: 3.393

Review 4. Alpha-blockade: monotherapy for hypertension and benign prostatic hyperplasia.

Authors: S A Kaplan; N M Kaplan
Journal: Urology Date: 1996-10 Impact factor: 2.649

5. Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia.

Authors: J T Andersen; J C Nickel; V R Marshall; C C Schulman; P Boyle
Journal: Urology Date: 1997-06 Impact factor: 2.649

6. Transurethral resection of the prostate vs high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: long-term results.

Authors: F C D'Ancona; E A Francisca; W P Witjes; L Welling; F M Debruyne; J J De La Rosette
Journal: Br J Urol Date: 1998-02

7. Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study.

Authors: M Ahmed; T Bell; W T Lawrence; J P Ward; G M Watson
Journal: Br J Urol Date: 1997-02

8. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.

Authors: J D McConnell; R Bruskewitz; P Walsh; G Andriole; M Lieber; H L Holtgrewe; P Albertsen; C G Roehrborn; J C Nickel; D Z Wang; A M Taylor; J Waldstreicher
Journal: N Engl J Med Date: 1998-02-26 Impact factor: 91.245

9. Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: results of a randomized, double-blind, multicenter, sham-controlled trial.

Authors: C G Roehrborn; G Preminger; P Newhall; J Denstedt; H Razvi; L J Chin; A Perlmutter; W Barzell; W Whitmore; R Fritzsch; J Sanders; S Sech; S Womack
Journal: Urology Date: 1998-01 Impact factor: 2.649

10. Transurethral prostatectomy: a prospective randomized study of conventional resection and electrovaporization in benign prostatic hyperplasia.

Authors: A A Shokeir; H al-Sisi; Y M Farage; M A el-Maaboud; M Saeed; H Mutabagani
Journal: Br J Urol Date: 1997-10

12 in total

Review 1. Management of bladder, prostatic and pelvic floor disorders.

Authors: G Brisinda; G Maria; A R Bentivoglio; F Cadeddu; G Marniga; F Brandara; A Albanese
Journal: Neurotox Res Date: 2006-04 Impact factor: 3.911

2. Effects of D-004, a lipid extract from Cuban royal palm fruit, on inhibiting prostatic hypertrophy induced with testosterone or dihydrotestosterone in a rat model: A randomized, controlled study.

Authors: Daisy Carbajal; Maria de Lourdes Arruzazabala; Más Rosa; Vivian Molina; Eduardo Rodríguez; Victor González
Journal: Curr Ther Res Clin Exp Date: 2004-11

3. Plasma levels, tissue distribution, and excretion of radioactivity after single-dose administration of ((3)H)-oleic acid added to D-004, a lipid extract of the fruit of Roystonea regia, in rats.

Authors: L Yohani Pérez; Roberto Menéndez; Rosa Más; Rosa M González
Journal: Curr Ther Res Clin Exp Date: 2006-11

4. In vitro effect of D-004, a lipid extract of the fruit of the cuban royal palm (Roystonea regia), on prostate steroid 5α-reductase activity.

Authors: L Yohani Pérez; Roberto Menéndez; Rosa Má; Rosa M González
Journal: Curr Ther Res Clin Exp Date: 2006-11

5. Transurethral intraprostatic Botulinum toxin-A injection: a novel treatment for BPH refractory to current medical therapy in poor surgical candidates.

Authors: Ali Hamidi Madani; Ahmad Enshaei; Abtin Heidarzadeh; Gholamreza Mokhtari; Alireza Farzan; Mani Mohiti Asli; Samaneh Esmaeili
Journal: World J Urol Date: 2012-03-13 Impact factor: 4.226

6. Effects of D-004, a lipid extract of the fruit of the Cuban royal palm (Roystonea regia) or the lipidosterolic extract of saw palmetto (Serenoa repens) on the sexual activity in male rats: A controlled, experimental study.

Authors: Lilia C Fernández; Rosa Mas; Julio Fernández; Sarahí Mendoza; Rafael Gámez; Balia Pardo
Journal: Curr Ther Res Clin Exp Date: 2008-02

7. Botulinum neurotoxin type A for the treatment of benign prostatic hyperplasia: randomized study comparing two doses.

Authors: René Arnouk; Carlos Henrique Suzuki Bellucci; Roberto Benatuil Stull; José de Bessa; Cesar Augusto Malave; Cristiano Mendes Gomes
Journal: ScientificWorldJournal Date: 2012-09-10

Review 8. Systematic review and meta-analysis of Transurethral Needle Ablation in symptomatic Benign Prostatic Hyperplasia.

Authors: Carmen Bouza; Teresa López; Angeles Magro; Lourdes Navalpotro; José María Amate
Journal: BMC Urol Date: 2006-06-21 Impact factor: 2.264

Review 9. Finasteride in the treatment of clinical benign prostatic hyperplasia: a systematic review of randomised trials.

Authors: Jayne E Edwards; R Andrew Moore
Journal: BMC Urol Date: 2002-12-12 Impact factor: 2.264

Review 10. Critical Analysis on Characterization, Systemic Effect, and Therapeutic Potential of Beta-Sitosterol: A Plant-Derived Orphan Phytosterol.

Authors: Muhammad Shahdaat Bin Sayeed; Selim Muhammad Rezaul Karim; Tasnuva Sharmin; Mohammed Monzur Morshed
Journal: Medicines (Basel) Date: 2016-11-15